Study compares single-inhaler triple therapies for treatment of COPD
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
BMJ11 天
Environmentally friendly inhaler regimens for COPD
is more effective in reducing the annual rate of exacerbations compared with LABA-LAMA or LABA-inhaled corticosteroid in patients with chronic obstructive pulmonary disease (COPD), a history of ...
pharmaphorum3 天
Smart sensor cleared for use with AZ asthma, COPD inhalers
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...
pharmaphorum6 天
Teva launches digital asthma and COPD rescue inhaler in US
Teva has launched new digital inhaler ... generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD ...
Verona Pharma's Ohtuvayre Defies Expectations In Q4, But Stock Alpha May Now Be Limited
Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...
Business Insider29 天
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers ...
“In the United States, while 93% of Teva’s inhaler medicines are generic products with access at lower prices – particularly for insured patients – there still remain uninsured patients ...